Newsroom

FDA clears acute infection and sepsis test

Recognizing It Early While Getting It Right: The Value of Novel Sepsis Testing Tools

A better, faster sepsis test that can save lives

Inflammatix Gets FDA Clearance for 30-Minute Sepsis Test, Preps for US Launch

Inflammatix Scores FDA Approval for Precision Infection Test

Inflammatix begins trial evaluating mRNA test for patient infection status

Inflammatix Adds MedTech Veteran as First General Counsel

Inflammatix Raises $57M in Series E Financing

Inflammatix collects $57M as it awaits FDA review of infectious disease test

Targeting FDA OK for its test against deadly sepsis, South Bay company raises $57 million

Rapid Tests Continue Push Into Sepsis Market in 2023 as Competition Heats Up

Inflammatix sepsis test scores FDA breakthrough device designation